Both in Pharmaceuticals
Spero Therapeutics vs Verrica Pharmaceuticals
Over the past year SPRO returned −49.8% and VRCA returned −8.3%; their daily moves had a correlation of 0.16.
SPRO −49.8% VRCA −8.3%Growth of $1, one year, split-adjusted
| Metric | SPRO | VRCA |
|---|---|---|
| Price | $1.11 | $3.53 |
| Market cap | $64.6M | $60.6M |
| Today | −1.77% | −7.83% |
| 1 month | −11.2% | −19.0% |
| 6 months | −59.5% | −49.4% |
| Year to date | −52.4% | −57.5% |
| 1 year | −50.7% | −9.7% |
| Revenue growth (YoY) | −100.0% | −53.8% |
| Gross margin | — | 85.0% |
| Net margin | — | −224.4% |
| P/E (TTM) | 8.8× | — |
| Price / sales | 1.4× | 2.0× |
| Net cash | $50.7M | $9.8M |
| Dividend yield | — | — |
| Volatility (60d) | 57.2% | 63.2% |
| Short % of float | 1.9% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).